Reneo Pharmaceuticals, Inc.
RPHM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $70 | $83 | $97 | $111 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $2 | $2 |
| Total Curr. Assets | $72 | $85 | $98 | $113 |
| Property Plant & Equip (Net) | $1 | $1 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $73 | $86 | $100 | $115 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $3 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $5 | $6 | $7 |
| Total Curr. Liab. | $6 | $8 | $9 | $11 |
| LT Debt | $0 | $0 | $0 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6 | $8 | $9 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $115 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$201 | -$186 | -$171 | -$155 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $267 | $264 | $261 | $259 |
| Total Equity | $66 | $78 | $91 | $104 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $73 | $86 | $100 | $115 |
| Net Debt | -$70 | -$83 | -$96 | -$110 |